MADRIGAL PHARMACEUTICALS INC's ticker is MDGL and the CUSIP is 558868105. A total of 142 filers reported holding MADRIGAL PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.55 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2024 | $560,784 | -85.0% | 2,100 | -87.0% | 0.00% | -87.5% |
| Q4 2023 | $3,748,356 | +50.1% | 16,200 | -5.3% | 0.01% | +33.3% |
| Q3 2023 | $2,497,284 | -19.9% | 17,100 | +26.7% | 0.01% | -33.3% |
| Q2 2023 | $3,118,500 | -8.1% | 13,500 | -3.6% | 0.01% | +28.6% |
| Q1 2023 | $3,391,640 | -18.3% | 14,000 | -2.1% | 0.01% | -41.7% |
| Q4 2022 | $4,150,575 | -41.6% | 14,300 | -86.9% | 0.01% | -45.5% |
| Q3 2022 | $7,106,000 | +513.1% | 109,336 | +574.9% | 0.02% | +450.0% |
| Q2 2022 | $1,159,000 | +412.8% | 16,200 | +604.0% | 0.00% | +300.0% |
| Q1 2022 | $226,000 | +5.6% | 2,301 | -8.7% | 0.00% | 0.0% |
| Q4 2021 | $214,000 | -92.9% | 2,520 | -90.1% | 0.00% | -94.1% |
| Q3 2020 | $3,028,000 | -1.3% | 25,500 | -5.9% | 0.02% | -15.0% |
| Q2 2020 | $3,067,000 | +326.0% | 27,085 | +242.8% | 0.02% | +300.0% |
| Q4 2019 | $720,000 | -40.2% | 7,900 | -31.3% | 0.01% | -50.0% |
| Q2 2019 | $1,205,000 | -2.9% | 11,500 | +16.2% | 0.01% | 0.0% |
| Q1 2019 | $1,241,000 | +12310.0% | 9,900 | +21421.7% | 0.01% | – |
| Q3 2018 | $10,000 | – | 46 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| University of Wisconsin Foundation | 73,487 | $17,003,422 | 28.29% |
| Tao Capital Management LP | 130,529 | $30,202 | 27.63% |
| Paulson & Co. | 1,105,741 | $255,846,353 | 23.09% |
| AlpInvest Partners B.V. | 211,488 | $48,934,093 | 11.18% |
| Bain Capital Life Sciences Investors, LLC | 324,619 | $75,110,344 | 7.20% |
| Avoro Capital Advisors LLC | 1,888,888 | $437,050,905 | 6.04% |
| Propel Bio Management, LLC | 30,032 | $6,948,804 | 5.76% |
| Baker Brothers Advisors | 1,969,798 | $455,771,861 | 5.19% |
| Rosalind Advisors, Inc. | 25,000 | $5,784,500 | 4.76% |
| TCG Crossover Management, LLC | 179,917 | $41,629,195 | 4.62% |